The evolving role of cyclin-dependent kinase inhibitors in cancer management

Clin Adv Hematol Oncol. 2017 Mar;15(3):174-177.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cyclin-Dependent Kinases / antagonists & inhibitors*
  • Cyclin-Dependent Kinases / metabolism
  • Humans
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / metabolism
  • Neoplasms* / drug therapy
  • Neoplasms* / enzymology
  • Protein Kinase Inhibitors / therapeutic use*

Substances

  • Antineoplastic Agents
  • Neoplasm Proteins
  • Protein Kinase Inhibitors
  • Cyclin-Dependent Kinases